NCT03144661 2025-10-21An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other MalignanciesIncyte CorporationPhase 1 Terminated25 enrolled
NCT04125693 2022-04-01Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its SafetyBayerPhase 2 Completed1 enrolled